Secondary stroke prevention in polish adults: results from the LIPIDOGRAM2015 study
File(s)
Published version
Author(s)
Type
Journal Article
Abstract
Background: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (n = 13,724), 268 subjects had a history of ischaemic stroke and were included. Results: 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (p = 0.047 and p = 0.012, respectively). A history of atrial fibrillation, CHD, and previous myocardial infarction correlated with anticoagulant treatment (p = 0.001, p = 0.011, and p < 0.0001, respectively). Age, gender, time from stroke onset, place of residence, and level of education were not associated with antiplatelet or anticoagulant treatment. Only 31.7% of patients were engaged in regular physical activity, 62% used appropriate diet, and 13.6% were current smokers. Conclusions: In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke.
Date Issued
2021-10-01
Date Acceptance
2021-09-21
Citation
Journal of Clinical Medicine, 2021, 10 (19)
ISSN
2077-0383
Publisher
MDPI AG
Journal / Book Title
Journal of Clinical Medicine
Volume
10
Issue
19
Copyright Statement
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/34640490
PII: jcm10194472
Subjects
ATRIAL-FIBRILLATION
CARDIOVASCULAR-DISEASE
General & Internal Medicine
GLOBAL BURDEN
GUIDELINES
ISCHEMIC-STROKE
Life Sciences & Biomedicine
Medicine, General & Internal
oral anticoagulant drugs
oral antiplatelet drugs
POLAND
primary health care
RISK
Science & Technology
secondary stroke prevention
STATINS
STYLE
SYSTEMATIC ANALYSIS
Publication Status
Published
Coverage Spatial
Switzerland
Article Number
4472
Date Publish Online
2021-09-28